Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$260.71 USD

260.71
1,424,061

+2.88 (1.12%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $260.81 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (159 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Aetna's Merger with Humana Foiled by Regulators, Stock Down

by Zacks Equity Research

Federal authorities reviewing the proposed Aetna Inc. (AET) and Humana Inc. (HUM) mega merger have now blocked the deal.

    5 Reasons Why Molina Healthcare Stock is a Solid Pick Now

    by Zacks Equity Research

    Molina Healthcare Stock seems to be attractive for the investors at this point of time despite uncertain vulnerability to the reform changes in the HMO industry.

      5 Reasons to Buy Magellan Health (MGLN) Stock Right Now

      by Zacks Equity Research

      Magellan Health Inc. (MGLN) is one stock that looks appealing with its strong fundamentals and improving prospects.

        Can UnitedHealth (UNH) Maintain Its Bull Run in 2017?

        by Zacks Equity Research

        UnitedHealth (UNH) looks well positioned for growth in 2017 by virtue of its diversified business in the health insurance space, exit from Exchanges for 2017 and high-growth Optum business.

          3 HMO Stocks to Consider as Aetna (AET) Falls Out of Favor

          by Zacks Equity Research

          Aetna Inc. (AET) has been grappling with a number of issues of late, which are clearly reflected in its share price underperformance relative to the sector.

            Aetna Continues to Grow Business, Merger Remains Uncertain

            by Zacks Equity Research

            On Dec 27, we issued an updated research report on Aetna Inc. (AET).

              Why UnitedHealth (UNH) Stands Tall Amid All the Noise

              by Zacks Equity Research

              UnitedHealth (UNH) has been able to beat all kinds of industry odds to emerge as a winner.

                Will You Hold Humana (HUM) Amid Aetna Merger Uncertainty?

                by Zacks Equity Research

                On Dec 19, 2016, Zacks Investment Research downgraded Humana Inc. (HUM) to a Zacks Rank #3 (Hold).

                  Zacks.com featured highlights: Nxstage Medical, Humana, Motorola Solutions, Evercore Partners and NTN Buzztime

                  by Zacks Equity Research

                  Zacks.com featured highlights: Nxstage Medical, Humana, Motorola Solutions, Evercore Partners and NTN Buzztime

                    UnitedHealth's Upcoming Note Issuance Rated by A.M Best

                    by Zacks Equity Research

                    UnitedHealth Group's (UNH) upcoming senior unsecured notes of $1.5 billion recently received rating action from A.M. Best. The rating giant has assigned a Long-Term Issue Credit Rating of ???bbb+??? to the same.

                      Ensign Group's Unit Sells Urgent Care Assets to MultiCare

                      by Zacks Equity Research

                      The Ensign Group, Inc. (ENSG) recently announced that its urgent care unit, Immediate Clinic Seattle, Inc., has completed its asset sale deal with not-for-profit health care organization,

                        Molina: ACA Repeal Plans a Threat, Buyout Deals on Track

                        by Zacks Equity Research

                        On Dec 15, 2016, we issued an updated research report on Molina Healthcare Inc. (MOH).

                          Community Health to Divest Yakima & Toppenish Hospitals

                          by Zacks Equity Research

                          Community Health Systems, Inc. (CYH) recently announced that its subsidiaries have entered into a definitive agreement with Sunnyside Community Hospital & Clinics

                            Aetna CEO Calls Pulling out of ACA Exchanges 'Good Business'

                            by Zacks Equity Research

                            Aetna Inc. (AET) recently came under fire for having allegedly pulled out of Affordable Care Act (ACA) exchanges in 11 states, including the areas covered by the Justice Department lawsuit, in a bid to avoid antitrust claims.

                              Humana (HUM) to Write off Receivables; Updates Guidance

                              by Zacks Equity Research

                              Humana Inc. (HUM) recently announced its decision to write off its receivables of $591 million associated with the risk corridor premium stabilization program outstanding as of Sep 30, 2016.

                                Humana, FullWell to Enhance Value-Based Care in Colorado

                                by Zacks Equity Research

                                Humana Inc. (HUM) recently announced that it has entered in to a value-based agreement with population health leader, FullWell

                                  Mark Vickery headshot

                                  Will Trump Era Mean Disaster for Health Insurers?

                                  by Mark Vickery

                                  Health insurance companies provided a major overhaul of their business plans to comply with Obamacare, and now they look to be put on a new road forward.

                                    WellCare Health Plans (WCG) and Unit Receive Rating Action

                                    by Zacks Equity Research

                                    WellCare Health Plans, Inc. (WCG) recently received rating action from credit rating giant, Moody's Investors Service, a wing of Moody's Corp. (MCO).

                                      UnitedHealth & CVS Pharmacy Partner to Improve Healthcare

                                      by Zacks Equity Research

                                      In keeping with the intention to provide convenient and low healthcare option to customers, UnitedHealth Group Inc.'s (UNH) pharmacy care services business - OptumRx - recently joined forces with CVS Pharmacy

                                        Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma

                                        by Zacks Equity Research

                                        Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma

                                          Humana Partners DaVita Unit to Enhance MA Plans in Florida

                                          by Zacks Equity Research

                                          Humana Inc. (HUM) recently joined forces with JSA Medical Group to add one primary care practice to its Florida Medicare Advantage (MA) Plan Networks.

                                            Health Insurers Face Regulatory Scrutiny, Exchange Issues

                                            by Zacks Equity Research

                                            Legislation has undoubtedly altered the regulatory landscape in ways that are not always beneficial to a private health insurer's bottom line.

                                              Indradip Ghosh headshot

                                              New Strong Buy Stocks for September 2nd

                                              by Indradip Ghosh

                                              Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday

                                                New Strong Buy Stocks for July 26th

                                                by Zacks Equity Research

                                                Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

                                                  Health Insurers Suffer on High Costs, Unprofitable Exchanges

                                                  by Zacks Equity Research

                                                  A fragile global economy presents a headwind for insurers looking to expand their international operations.